Attending #HRS2024 ? Don’t miss our Rhythm Theater events where we will go over the latest advancements in AF Management, see what’s trending in #LAAC and exploring the clinical evolution of FARAPULSE™.

Experience the transformative power of FARAPULSE™: Treating over 40,000 patients globally, it leads in research and clinical evidence among #PulsedFieldAblation systems, revolutionizing paroxysmal #AFib treatment. bit.ly/4aMvHoR

Safety info: bit.ly/4aTfluv

Join us on April 30th for a CTO live case broadcast from the University of Washington with Drs. William Lombardi and Kate Kearney, plus pre and post procedure discussions with Dr. Gus Theodos, BJC Healthcare.

Register now: bit.ly/4b4YYup

The LUX-Dx II+™ ICM System's enhanced AF algorithm reduces false positives and the number of episodes for review. Learn more: bit.ly/3xQyM8Q

Safety info: bit.ly/448AONy

At 12 months, patients treated with POLARx™ FIT experienced 82% freedom from atrial arrhythmia and no primary safety events. Explore the FROzEN AF trial data: bit.ly/3w1ezMW

Safety info: bit.ly/4dau59K

Using recent S-ICD technologies and implant technique, one year S-ICD inappropriate shock rates are less than 2% as demonstrated in two clinical studies. See the studies: bit.ly/3Q8SYJi

Safety info: bit.ly/4bjO1FN

Recent data published in the Heart Rhythm Journal highlights that SmartDelay AVO was superior to Fixed AV Delay to improve CRT response among patients with prolonged interventricular delays. See the data: bit.ly/3JmPkHS

Safety info: bit.ly/3JmPkYo

#PulsedFieldAblation , the future of #AFib treatment is expected to dominate 60%+ of procedures by 2028. Discover why the medical world is buzzing with excitement. Dive in with The Wall Street Journal! partners.wsj.com/boston-scienti…

Thanks to everyone who helped make #ACC24 a huge success! We enjoyed meeting many of you and appreciate everyone stopping by the Relax and Recharge Lounge – sponsored by WATCHMAN – for an opportunity to unwind with rescue puppies.

The 12-month clinical data on POLARx™ FIT is in! At one year, 100% of patients were free of any primary safety event. See the FROzEN AF trial findings: bit.ly/4auPglc

Safety info: bit.ly/3TKNfu8

What a weekend! We're so happy for Jacqueline #jacci Peaches and Erica Spatz. Thank you to Furkids, Inc. for helping the WATCHMAN team spread so much joy at #ACC24

Don’t miss your opportunity to spend time with our guests from Furkids, Inc.. Puppies are here from 9-3 today. See you at booth #1601. #ACC24